BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12764129)

  • 21. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
    Subramanian L; Benson MD; Iñiguez-Lluhí JA
    J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Jak2 tyrosine kinase residues glutamic acid 1024 and arginine 1113 form a hydrogen bond interaction that is essential for Jak-STAT signal transduction.
    Sandberg EM; VonDerLinden D; Ostrov DA; Sayeski PP
    Mol Cell Biochem; 2004 Oct; 265(1-2):161-9. PubMed ID: 15543946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs.
    Melen K; Kinnunen L; Julkunen I
    J Biol Chem; 2001 May; 276(19):16447-55. PubMed ID: 11150296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repression and coactivation of CCAAT/enhancer-binding protein epsilon by sumoylation and protein inhibitor of activated STATx proteins.
    Kim J; Sharma S; Li Y; Cobos E; Palvimo JJ; Williams SC
    J Biol Chem; 2005 Apr; 280(13):12246-54. PubMed ID: 15661739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SUMO-1 modification of MEF2A regulates its transcriptional activity.
    Riquelme C; Barthel KK; Liu X
    J Cell Mol Med; 2006; 10(1):132-44. PubMed ID: 16563226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PIAS/SUMO: new partners in transcriptional regulation.
    Schmidt D; Müller S
    Cell Mol Life Sci; 2003 Dec; 60(12):2561-74. PubMed ID: 14685683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of yeast PIAS-type SUMO ligases in vivo and in vitro.
    Takahashi Y; Toh-E A; Kikuchi Y
    J Biochem; 2003 Apr; 133(4):415-22. PubMed ID: 12761287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-translational modification of Rta of Epstein-Barr virus by SUMO-1.
    Chang LK; Lee YH; Cheng TS; Hong YR; Lu PJ; Wang JJ; Wang WH; Kuo CW; Li SS; Liu ST
    J Biol Chem; 2004 Sep; 279(37):38803-12. PubMed ID: 15229220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine-induced paracrystals prolong the activity of signal transducers and activators of transcription (STAT) and provide a model for the regulation of protein solubility by small ubiquitin-like modifier (SUMO).
    Droescher M; Begitt A; Marg A; Zacharias M; Vinkemeier U
    J Biol Chem; 2011 May; 286(21):18731-46. PubMed ID: 21460228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PIASx acts as an Elk-1 coactivator by facilitating derepression.
    Yang SH; Sharrocks AD
    EMBO J; 2005 Jun; 24(12):2161-71. PubMed ID: 15920481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PIAS proteins: pleiotropic interactors associated with SUMO.
    Rytinki MM; Kaikkonen S; Pehkonen P; Jääskeläinen T; Palvimo JJ
    Cell Mol Life Sci; 2009 Sep; 66(18):3029-41. PubMed ID: 19526197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription.
    Palvimo JJ
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1405-8. PubMed ID: 18031232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of Tbx5-mediated transactivation by SUMO conjugation and protein inhibitor of activated STAT 1 (PIAS1).
    Beketaev I; Kim EY; Zhang Y; Yu W; Qian L; Wang J
    Int J Biochem Cell Biol; 2014 May; 50():82-92. PubMed ID: 24582888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of the erythroid transcription factor GATA-1 by SUMO-1.
    Collavin L; Gostissa M; Avolio F; Secco P; Ronchi A; Santoro C; Del Sal G
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8870-5. PubMed ID: 15173587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9.
    Hattori T; Eberspaecher H; Lu J; Zhang R; Nishida T; Kahyo T; Yasuda H; de Crombrugghe B
    J Biol Chem; 2006 May; 281(20):14417-28. PubMed ID: 16554309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a C-Terminal SUMO-Interacting Motif Present in Select PIAS-Family Proteins.
    Lussier-Price M; Mascle XH; Cappadocia L; Kamada R; Sakaguchi K; Wahba HM; Omichinski JG
    Structure; 2020 May; 28(5):573-585.e5. PubMed ID: 32348746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MAPK-induced Ser727 phosphorylation promotes SUMOylation of STAT1.
    Vanhatupa S; Ungureanu D; Paakkunainen M; Silvennoinen O
    Biochem J; 2008 Jan; 409(1):179-85. PubMed ID: 17897103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of cardiac specific nkx2.5 gene activity by small ubiquitin-like modifier.
    Wang J; Zhang H; Iyer D; Feng XH; Schwartz RJ
    J Biol Chem; 2008 Aug; 283(34):23235-43. PubMed ID: 18579533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A transcriptional corepressor of Stat1 with an essential LXXLL signature motif.
    Liu B; Gross M; ten Hoeve J; Shuai K
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3203-7. PubMed ID: 11248056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sumoylated SnoN represses transcription in a promoter-specific manner.
    Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
    J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.